Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Trevi Therapeutics, Inc. | 675 000 | déclaré | 19 févr. 2026 | tx 41+4 153 056−325 078 |
| RHYTHM PHARMACEUTICALS, INC. | 7 037 | déclaré | 24 juin 2025 | tx 39+220 749−174 000 |
| PENWEST PHARMACEUTICALS CO | 0 | déclaré | 20 sept. 2010 | tx 19+704 500−427 994 |
| COLUMBIA LABORATORIES INC | 0 | déclaré | 14 août 2018 | tx 2+15 000−15 000 |
1 achat déclaré après au moins 12 mois de silence — dernière occurrence le 09 mai 2019.
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 19 févr. 2026 | GRANT_AWARD | Trevi Therapeutics, Inc. | 675 000 | 0.00 USD | deriv |
| 24 juin 2025 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 7 037 | 0.00 USD | deriv |
| 24 juin 2025 | GRANT_AWARD | RHYTHM PHARMACEUTICALS, INC. | 4 712 | 0.00 USD | deriv |
| 18 juin 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4 000 | — | |
| 18 juin 2025 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4 000 | 0.00 USD | deriv |
| 31 mai 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 102 000 | 0.00 USD | deriv |
| 21 mars 2025 | EXERCISE | Trevi Therapeutics, Inc. | 5 263 | 1.43 USD | |
| 21 mars 2025 | SALE | Trevi Therapeutics, Inc. | 5 263 | 6.58 USD | |
| 21 mars 2025 | EXERCISE | Trevi Therapeutics, Inc. | 5 263 | 0.00 USD | deriv |
| 10 mars 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 54 400 | 0.00 USD | deriv |
| 18 févr. 2025 | GRANT_AWARD | Trevi Therapeutics, Inc. | 811 000 | 0.00 USD | deriv |
| 17 sept. 2024 | SALE | RHYTHM PHARMACEUTICALS, INC. | 31 751 | 52.40 USD | |
| 17 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 15 000 | 22.93 USD | |
| 17 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 9 250 | 21.37 USD | |
| 17 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 7 501 | 18.99 USD | |
| 17 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 9 250 | 0.00 USD | deriv |
| 17 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 7 501 | 0.00 USD | deriv |
| 17 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 15 000 | 0.00 USD | deriv |
| 09 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 1 736 | 18.99 USD | |
| 09 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4 305 | 21.37 USD | |
| 09 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 12 900 | 22.93 USD | |
| 09 sept. 2024 | SALE | RHYTHM PHARMACEUTICALS, INC. | 37 241 | 50.45 USD | |
| 09 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 18 300 | 4.15 USD | |
| 09 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 18 300 | 0.00 USD | deriv |
| 09 sept. 2024 | EXERCISE | RHYTHM PHARMACEUTICALS, INC. | 4 305 | 0.00 USD | deriv |